Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn’t Miss
@myesmo.bsky.social
oncodaily.com/insight/esmo...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMOTATASIA25
15 Posts Not to Miss from ESMO TAT Asia 2025
@myesmo.bsky.social
@jiajennyliu.bsky.social @anmwongnz.bsky.social @rashidlui.bsky.social @omalirp.bsky.social @herbloongmd.bsky.social
oncodaily.com/societies/15...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMOTATAsia25
📖 The ESMO Targeted Anticancer Therapies Asia Congress 2025 resources are now available on OncologyPro. 🔗 buff.ly/OSLsJ2x
📚 Explore cutting-edge discoveries and expert-led discussions from #ESMOTATAsia25 - where the science of early-phase oncology meets innovation.
#AntiDrugConjugates in #LungCancer. In an Opinion piece in the #ESMODailyReporter, Tony Mok reviews data from recent #ClinicalTrials using HER2-, HER3- on TROP2-targeted #ADCs.
🔗 buff.ly/293gWvr
#ESMOTATAsia25
Did you know - Molecular Cancer Therapeutics is the central hub for #FirstDisclosures in cancer. Catch up on the latest articles: buff.ly/xzopCbo #ESMOTATAsia25
#ESMOTATAsia25: Exploratory #omics and #MachineLearning revealed an 11-gene signature associated with response after #chemoradiotherapy for #CervicalCancer. MMP2 was identified as a key target.
Read more in the #ESMODailyReporter
🔗 buff.ly/cHluzz7
#ESMOTATAsia25: In an Opinion piece in the #ESMODailyReporter, Lillian Siu discusses the growth of early #oncology #ClinicalTrials in #AsiaPacific but highlights the need for improved trial access in low- and middle-income countries.
🔗 dailyreporter.esmo.org/esmo-targete...
Check out the Developmental Therapeutics Collection, highlighting therapeutics currently in preclinical to early clinical development. #ESMOTATAsia25
#ESMOTATAsia25: Presentations highlight the value of integrating #PatientReportedOutcomes (#PRO) into #EarlyPhaseTrials with guidance on standardisation.
Read more in the #ESMODailyReporter
🔗 dailyreporter.esmo.org/esmo-targete...
🙌 Welcome to #ESMOTATAsia25!
The Congress kicks off today — get ready for cutting-edge insights in targeted therapies and early drug development.
👉 Join us to accelerate novel cancer therapeutics across the APAC region: #Oncology #CancerResearch
🔗 buff.ly/wZIsR9E
Assistant Editor of Molecular Cancer Therapeutics, Danielle Large, PhD, will be attending #ESMOTATAsia25. Reach out to her at danielle.large@aacr.org to schedule a meeting to discuss your ongoing research or to learn more about publishing at the journal!
Putting final touches together to my talk😀. Looking forward to welcoming you all to #hongkong 🇭🇰 for #ESMOTATAsia25! Don't be shy - come by and say hi!
#drugdevelopment @cuhkmedicine.bsky.social @apoddc @APCLC_2023
One week until the inaugural #ESMOTATAsia25 🤩
I'm looking forward to joining global drug development experts in🍜🇭🇰
+ sharing insights on dose optimisation of novel combinations
🗓️ Saturday 19 July 2pm.
@myesmo.bsky.social @herbloongmd.bsky.social @anmwongnz.bsky.social
Come join us in #hongkong 🇭🇰 🍜🥟🥡 for the #inaugural @myesmo.bsky.social #ESMOTATAsia25 on July 18-20, 2025! We have assembled a #stellar group of #international #faculties and #experts in #drugdevelopment to help move the field forward. Register today!
📣Final call for early registration! The #ESMOTATAsia25 early registration fees are ending soon.
⏰Register by 14 May and be part of the future of cancer #drugdevelopment.
🔗 buff.ly/e1yAPUD
⏰ Less than 1 week left to submit your abstract to #ESMOTATAsia25. Let's accelerate the development of #earlyphasetrials in the region together.
👉 Submit your research by 29 April by 18:00 Hong Kong Time
🔗 buff.ly/nlzr3GY
⏰Less than 2 weeks left to submit your abstract to #ESMOTATAsia25! A fantastic opportunity to showcase your transformative work within the region in a truly international platform.
👉Submit your research by 29 April by 18:00 Hong Kong Time
🔗 buff.ly/nOD4Kzs
👉 Share your findings with regional and international experts in #cancer #drugdevelopment.
⏰ You still have 3 weeks to submit your abstract to #ESMOTATAsia25, a new platform to improve cancer care in the region
Submit now:
🔗 buff.ly/IdnoYdO
